A pilot study to search possible mechanisms of ultralong gonadotropin-releasing hormone agonist therapy in IVF-ET patients with endometriosis

BACKGROUND: Additional treatment with a gonadotropin-releasing hormone (GnRH) agonist (GnRHa) before IVF-ET (ultralong GnRHa therapy) has been reported to improve the outcome of IVF-ET in endometriosis patients. However, the mechanism of ultralong GnRHa therapy is unclear. It is suggested that infla...

Descripción completa

Detalles Bibliográficos
Autores principales: Tamura, Hiroshi, Takasaki, Akihisa, Nakamura, Yasuhiko, Numa, Fumitaka, Sugino, Norihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4207622/
https://www.ncbi.nlm.nih.gov/pubmed/25331066
http://dx.doi.org/10.1186/s13048-014-0100-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4207622/
https://www.ncbi.nlm.nih.gov/pubmed/25331066
http://dx.doi.org/10.1186/s13048-014-0100-8

Ejemplares similares